Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
07 October, 2015 13:53 IST
Panacea ties with Kremers for 11 high entry barrier generics
Source: IRIS | 19 Nov, 2012, 12.06PM
Comments  |  Post Comment

Panacea Biotec, India's highly progressive research based health managment company has entered into a strategic alliance with Kremers Urban Inc. for 11 high barrier to entry generice, whose market size in US at the innovator level is around USD 4 billion.

The first product in this portfolio is to reach the market in Tacrolimus Capsules that is being launched in US in Nov 2012.

Commenting on the development, Rajesh Jain managing director, Panacea Biotech (Q,N,C,F)* said, ''Panacea Biotech's proven track record in building strong, collaborative working relationship is a key driver for this strategic alliance with Kremers Under that will accelerate the company's growth plans in the US. Approval of Tacrolimus from US-FDA is the first milestone achieved in Panacea Biotec's long term plans for USA; the largest pharmaceutical market in the world. This would be followed by a series of high barrier to entry generic product launches that are being developed by the company. The commercialization strength of Kremars Urban for high barrier to entry generics perfectly synergizes with Panacea Biotec's research, development and manufacturing capabilities for such complex products forming a true win-win strategic alliance.''

Shares of Panacea Biotec gained Rs 8.1, or 7.64%, to trade at Rs 114.10. The total volume of shares traded was 29,308 at the BSE (12.01 p.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
DIIs increase stake in ICRA - 07-Oct-2015 12:46
DIIs raise shareholding in Cadila Healthcare - 07-Oct-2015 12:38
DIIs cut stake in Biocon; FIIs increase exposure - 07-Oct-2015 12:17
Punj Lloyd wins order worth Rs 4.88 bn - 07-Oct-2015 12:09
Redington's arm to acquire 70% stake in Linkplus - 07-Oct-2015 11:59
NMDC incorporates subsidiary to develop Jharkhand steel plants - 07-Oct-2015 11:52
Reliance Securities recommends 'Buy' on PVR; target Rs 1,000 - 07-Oct-2015 11:23
Visagar Polytex approves 3% final dividend for FY15 - 07-Oct-2015 11:12
Jubilant Life Sciences gets USFDA nod for Indomethacin ER capsule - 07-Oct-2015 11:06
Aditya Birla Nuvo dilutes 49% stake in renewables unit to Abraaj Group - 07-Oct-2015 09:59
Chemoil divests 49% stake in JV to Adani - 06-Oct-2015 19:50
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer